Very interesting, intuitively my thoughts went on to think, in this case I believe the mechanism of action of Trofinetide is barely understood. Could that be the reason of the lack of traction?
I cant recall the exact post, but I remember someone referred in a post to a statement someone from ACADIA did. I cant remember the exact words, but in essence they were saying: "We don't know exactly what Trofinetide does, but we are excited about it". <- please correct me if I remember it wrong.
Also, I have to admit that our management does very little to promote the product. Wonder why ....
ACADIA TALKS TROFINETIDE, page-69
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B | |||
| Open | High | Low | Value | Volume |
| $15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 125 | $16.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.20 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |